AB 1278: Physicians and surgeons: payments: disclosure: notice.
- Session Year: 2021-2022
- House: Assembly
- Latest Version Date: 2022-09-29
Existing law, the Medical Practice Act, establishes the Medical Board of California within the Department of Consumer Affairs and sets forth its powers and duties relating to the licensure and regulation of physicians and surgeons. Existing law establishes the Osteopathic Medical Board of California within the department and sets forth its powers and duties relating to the licensure and regulation of osteopathic physicians and surgeons.
Existing federal law known as the Open Payments program requires, among other things, applicable manufacturers of drugs, devices, and biological or medical supplies to annually report to the federal Secretary of Health and Human Services certain payments and other transfers of value made to covered recipients, as defined. The federal Centers for Medicare and Medicaid Services makes this Open Payments data available to the public via a federal government internet website.
Existing law, the Sherman Food, Drug, and Cosmetic Law, regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. That existing law specifically regulates drug marketing practices and requires a pharmaceutical company to adopt and update a program that includes policies on interactions with health care professionals and limits on gifts and incentives to medical or health professionals, as defined. Existing law requires each pharmaceutical company to establish in its program a specific annual dollar limit on gifts, promotional materials, or items or activities that the pharmaceutical company may give or otherwise provide to an individual medical or health care professional, with certain exemptions.
This bill would require a physician and surgeon, defined to include a physician and surgeon licensed pursuant to the Medical Practice Act or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act, to provide to a patient at the initial office visit a written or electronic notice of the Open Payments database, as prescribed.
This bill would require a physician and surgeon to post an Open Payments database notice, as described, in each location where the licensee practices and in an area that is likely to be seen by all persons who enter the office. The bill would, beginning January 1, 2024, require a physician and surgeon to conspicuously post the same Open Payments database notice on the internet website used for the physician and surgeons practice, if such a website is used, except as provided. If the physician and surgeon is employed by a health care employer, the bill would instead require the health care employer to comply with these posting requirements.
This bill would define other terms for its purposes. A violation of the bills provisions would constitute unprofessional conduct. The bill would specify that these provisions do not apply to a physician and surgeon working in a hospital emergency room.
Existing law, the Medical Practice Act, establishes the Medical Board of California within the Department of Consumer Affairs and sets forth its powers and duties relating to the licensure and regulation of physicians and surgeons. Existing law establishes the Osteopathic Medical Board of California within the department and sets forth its powers and duties relating to the licensure and regulation of osteopathic physicians and surgeons.
Existing federal law known as the Open Payments program requires, among other things, applicable manufacturers of drugs, devices, and biological or medical supplies to annually report to the federal Secretary of Health and Human Services certain payments and other transfers of value made to covered recipients, as defined. The federal Centers for Medicare and Medicaid Services makes this Open Payments data available to the public via a federal government internet website.
Existing law, the Sherman Food, Drug, and Cosmetic Law, regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. That existing law specifically regulates drug marketing practices and requires a pharmaceutical company to adopt and update a program that includes policies on interactions with health care professionals and limits on gifts and incentives to medical or health professionals, as defined. Existing law requires each pharmaceutical company to establish in its program a specific annual dollar limit on gifts, promotional materials, or items or activities that the pharmaceutical company may give or otherwise provide to an individual medical or health care professional, with certain exemptions.
This bill would require a physician and surgeon, defined to include a physician and surgeon licensed pursuant to the Medical Practice Act or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act, to provide to a patient at the initial office visit a written or electronic notice of the Open Payments database, as prescribed.
This bill would require a physician and surgeon to post an Open Payments database notice, as described, in each location where the licensee practices and in an area that is likely to be seen by all persons who enter the office. The bill would, beginning January 1, 2024, require a physician and surgeon to conspicuously post the same Open Payments database notice on the internet website used for the physician and surgeons practice, if such a website is used, except as provided. If the physician and surgeon is employed by a health care employer, the bill would instead require the health care employer to comply with these posting requirements.
This bill would define other terms for its purposes. A violation of the bills provisions would constitute unprofessional conduct. The bill would specify that these provisions do not apply to a physician and surgeon working in a hospital emergency room.
Existing law, the Medical Practice Act, establishes the Medical Board of California within the Department of Consumer Affairs and sets forth its powers and duties relating to the licensure and regulation of physicians and surgeons. Existing law establishes the Osteopathic Medical Board of California within the department and sets forth its powers and duties relating to the licensure and regulation of osteopathic physicians and surgeons.
Existing federal law known as the Open Payments program requires, among other things, applicable manufacturers of drugs, devices, and biological or medical supplies to annually report to the federal Secretary of Health and Human Services certain payments and other transfers of value made to covered recipients, as defined. The federal Centers for Medicare and Medicaid Services makes this Open Payments data available to the public via a federal government internet website.
Existing law, the Sherman Food, Drug, and Cosmetic Law, regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. That existing law specifically regulates drug marketing practices and requires a pharmaceutical company to adopt and update a program that includes policies on interactions with health care professionals and limits on gifts and incentives to medical or health professionals, as defined. Existing law requires each pharmaceutical company to establish in its program a specific annual dollar limit on gifts, promotional materials, or items or activities that the pharmaceutical company may give or otherwise provide to an individual medical or health care professional, with certain exemptions.
This bill would require a physician and surgeon, defined to include a physician and surgeon licensed pursuant to the Medical Practice Act or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act, to provide to a patient at the initial office visit, and every 2 years thereafter, visit a written or electronic notice of the Open Payments database, as prescribed.
This bill would require a physician and surgeon to post an Open Payments database notice, as described, in each location where the licensee practices and in an area that is likely to be seen by all persons who enter the office. The bill would would, beginning January 1, 2024, require a physician and surgeon to conspicuously post the same Open Payments database notice on the internet website used for the physician and surgeons practice. practice, if such a website is used, except as provided. If the physician and surgeon is employed by a health care employer, the bill would instead require the health care employer to comply with these posting requirements.
This bill would define other terms for its purposes. A violation of the bills provisions would constitute unprofessional conduct. The bill would specify that these provisions do not apply to a physician and surgeon working in a hospital emergency room.
Existing law, the Medical Practice Act, establishes the Medical Board of California within the Department of Consumer Affairs and sets forth its powers and duties relating to the licensure and regulation of physicians and surgeons. Existing law establishes the Osteopathic Medical Board of California within the department and sets forth its powers and duties relating to the licensure and regulation of osteopathic physicians and surgeons.
Existing federal law known as the Open Payments program requires, among other things, applicable manufacturers of drugs, devices, and biological or medical supplies to annually report to the federal Secretary of Health and Human Services certain payments and other transfers of value made to covered recipients, as defined. The federal Centers for Medicare and Medicaid Services makes this Open Payments data available to the public via a federal government internet website.
Existing law, the Sherman Food, Drug, and Cosmetic Law, regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. That existing law specifically regulates drug marketing practices and requires a pharmaceutical company to adopt and update a program that includes policies on interactions with health care professionals and limits on gifts and incentives to medical or health professionals, as defined. Existing law requires each pharmaceutical company to establish in its program a specific annual dollar limit on gifts, promotional materials, or items or activities that the pharmaceutical company may give or otherwise provide to an individual medical or health care professional, with certain exemptions.
This bill would require a physician and surgeon, defined to include a physician and surgeon licensed pursuant to the Medical Practice Act or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act, to provide to each a patient at the initial office visit, and at an office or telehealth visit annually every 2 years thereafter, a written notice of the Open Payments database, as prescribed.
This bill would require a physician and surgeon to post an Open Payments database notice, as described, in each location where the licensee practices and in an area that is likely to be seen by all persons who enter the office. The bill would require a physician and surgeon to conspicuously post the same Open Payments database notice on the internet website used for the physician and surgeons practice. If the physician and surgeon is employed by a health care employer, the bill would instead require the health care employer to comply with these posting requirements.
This bill would define other terms for its purposes. A violation of the bills provisions would constitute unprofessional conduct. The bill would specify that these provisions do not apply to a physician and surgeon working in a hospital emergency room.
Existing law, the Medical Practice Act, establishes the Medical Board of California within the Department of Consumer Affairs and sets forth its powers and duties relating to the licensure and regulation of physicians and surgeons. Existing law establishes the Osteopathic Medical Board of California within the department and sets forth its powers and duties relating to the licensure and regulation of osteopathic physicians and surgeons.
Existing federal law known as the Open Payments program requires, among other things, applicable manufacturers of drugs, devices, and biological or medical supplies to annually report to the federal Secretary of Health and Human Services certain payments and other transfers of value made to covered recipients, as defined. The federal Centers for Medicare and Medicaid Services makes this Open Payments data available to the public via a federal government internet website.
Existing law, the Sherman Food, Drug, and Cosmetic Law, regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. That existing law specifically regulates drug marketing practices and requires a pharmaceutical company to adopt and update a program that includes policies on interactions with health care professionals and limits on gifts and incentives to medical or health professionals, as defined. Existing law requires each pharmaceutical company to establish in its program a specific annual dollar limit on gifts, promotional materials, or items or activities that the pharmaceutical company may give or otherwise provide to an individual medical or health care professional, with certain exemptions.
This bill would require a physician and surgeon, defined to include a physician and surgeon licensed pursuant to the Medical Practice Act or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act, to provide to each patient at the initial office visit, and at an office or telehealth visit annually thereafter, a written notice of the Open Payments database, as prescribed. The bill would also require at such a visit, and annually thereafter, a written disclosure of the names of all drug and device companies the physician and surgeon received payment or transfers of value from, as reported on the Open Payment database for the 3 most recent years available, as prescribed.
This bill would require a physician and surgeon to post an Open Payments database notice, as described, in each location where the licensee practices and in an area that is likely to be seen by all persons who enter the office. The bill would require a physician and surgeon to conspicuously post the same Open Payments database notice on the internet website used for the physician and surgeons practice. If the physician and surgeon is employed by a health care employer, the bill would instead require the health care employer to comply with these posting requirements.
This bill would define other terms for its purposes. A violation of the bills provisions would constitute unprofessional conduct. The bill would specify that these provisions do not apply to a physician and surgeon working in a hospital emergency room.
Existing law, the Medical Practice Act, establishes the Medical Board of California within the Department of Consumer Affairs and sets forth its powers and duties relating to the licensure and regulation of physicians and surgeons. Existing law establishes the Osteopathic Medical Board of California within the department and sets forth its powers and duties relating to the licensure and regulation of osteopathic physicians and surgeons.
Existing federal law known as the Open Payments program requires, among other things, applicable manufacturers of drugs, devices, and biological or medical supplies to annually report to the federal Secretary of Health and Human Services certain payments and other transfers of value made to covered recipients, as defined. The federal Centers for Medicare and Medicaid Services makes this Open Payments data available to the public via a federal government internet website.
Existing law, the Sherman Food, Drug, and Cosmetic Law, regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. That existing law specifically regulates drug marketing practices and requires a pharmaceutical company to adopt and update a program that includes policies on interactions with health care professionals and limits on gifts and incentives to medical or health professionals, as defined. Existing law requires each pharmaceutical company to establish in its program a specific annual dollar limit on gifts, promotional materials, or items or activities that the pharmaceutical company may give or otherwise provide to an individual medical or health care professional, with certain exemptions.
This bill would require a physician and surgeon, defined to include a physician and surgeon licensed pursuant to the Medical Practice Act or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act, who receives a payment or transfer of value from a drug or device company, to disclose the source of the payment or transfer of value in writing to each patient or patient representative prior to the intended use or prescription of a device or drug manufactured or distributed by the company, to provide to each patient at the initial office visit, and at an office or telehealth visit annually thereafter, a written notice of the Open Payments database, as prescribed. The bill would also require at such a visit, and annually thereafter, a written disclosure of the names of all drug and device companies the physician and surgeon received payment or transfers of value from, as reported on the Open Payment database for the 3 most recent years available, as prescribed.
This bill would require a physician and surgeon to post an open payments Open Payments database notice, as described, in each location where the licensee practices and in an area that is likely to be seen by all persons who enter the office. The bill would require a physician and surgeon to conspicuously post the same open payments Open Payments database notice on the internet website used for the physician and surgeons practice. If the physician and surgeon is employed by a health care employer, the bill would instead require a the health care employer to comply with these posting requirements.
This bill would define other terms for its purposes. A violation of the bills provisions would constitute unprofessional conduct. The bill would specify that these provisions do not apply to a physician and surgeon working in a hospital emergency room.
Existing law, the Medical Practice Act, establishes the Medical Board of California within the Department of Consumer Affairs and sets forth its powers and duties relating to the licensure and regulation of physicians and surgeons. Existing law establishes the Osteopathic Medical Board of California within the department and sets forth its powers and duties relating to the licensure and regulation of osteopathic physicians and surgeons.
Existing federal law known as the Open Payments program requires, among other things, applicable manufacturers of drugs, devices, and biological or medical supplies to annually report to the federal Secretary of Health and Human Services certain payments and other transfers of value made to covered recipients, as defined.
Existing law, the Sherman Food, Drug, and Cosmetic Law, regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. That existing law specifically regulates drug marketing practices and requires a pharmaceutical company to adopt and update a program that includes policies on interactions with health care professionals and limits on gifts and incentives to medical or health professionals, as defined. Existing law requires each pharmaceutical company to establish in its program a specific annual dollar limit on gifts, promotional materials, or items or activities that the pharmaceutical company may give or otherwise provide to an individual medical or health care professional, with certain exemptions.
This bill would require a physician and surgeon, defined to include a physician and surgeon licensed pursuant to the Medical Practice Act or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act, who receives remuneration a payment or transfer of value from a drug or device company, to disclose the source of the remuneration orally and payment or transfer of value in writing to each patient or patient representative prior to the intended use or prescription of a device or drug manufactured or distributed by the company, as prescribed.
This bill would require a physician and surgeon to post an open payments database notice, as described, in each location where the licensee practices and in an area that is likely to be seen by all persons who enter the office. The bill would require a physician and surgeon to conspicuously post the same open payments database notice on the internet website used for the physician and surgeons practice. If the physician and surgeon is employed by a health care employer, the bill would instead require a health care employer to comply with these posting requirements.
This bill would define other terms for its purposes. A violation of the bills provisions would constitute unprofessional conduct. The bill would specify that these provisions do not apply to a physician and surgeon working in a hospital emergency room.
Existing law, the Medical Practice Act, establishes the Medical Board of California within the Department of Consumer Affairs and sets forth its powers and duties relating to the licensure and regulation of physicians and surgeons. Existing law establishes the Osteopathic Medical Board of California within the department and sets forth its powers and duties relating to the licensure and regulation of osteopathic physicians and surgeons.
Under existing law, it is unlawful for healing arts licensees, except as specified, to offer, deliver, receive, or accept any rebate, refund, commission, preference, patronage dividend, discount, or other consideration, in the form of money or otherwise, as compensation or inducement for referring patients, clients, or customers to any person, subject to certain exceptions. Existing law also prohibits specified healing arts licensees from charging, billing, or otherwise soliciting payment from a patient on behalf of, or referring a patient to, an organization in which the licensee, or the licensees immediate family, has a significant beneficial interest, unless the licensee first makes specified disclosures in writing to the patient.Existing federal law known as the Open Payments program requires, among other things, applicable manufacturers of drugs, devices, and biological or medical supplies to annually report to the federal Secretary of Health and Human Services certain payments and other transfers of value made to covered recipients, as defined.
Existing law, the Sherman Food, Drug, and Cosmetic Law, regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. That existing law specifically regulates drug marketing practices and requires a pharmaceutical company to adopt and update a program that includes policies on interactions with health care professionals and limits on gifts and incentives to medical or health professionals, as defined. Existing law requires each pharmaceutical company to establish in its program a specific annual dollar limit on gifts, promotional materials, or items or activities that the pharmaceutical company may give or otherwise provide to an individual medical or health care professional, with certain exemptions.
This bill would require a physician and surgeon, defined to include a physician and surgeon licensed pursuant to the Medical Practice Act or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act, who receives remuneration from a drug or device company, to disclose the source of the remuneration orally and in writing to each patient or patient representative prior to the intended use or prescription of a device or drug manufactured or distributed by the company, as prescribed. The bill would also define other terms for its purposes. Under the bill, a violation of this disclosure provision would constitute unprofessional conduct.
This bill would require a physician and surgeon to post an open payments database notice, as described, in each location where the licensee practices and in an area that is likely to be seen by all persons who enter the office. The bill would require a physician and surgeon to conspicuously post the same open payments database notice on the internet website used for the physician and surgeons practice. The If the physician and surgeon is employed by a health care employer, the bill would instead require a health care employer to comply with these posting requirements instead if the physician and surgeon is employed by the health care employer. requirements.
This bill would require the responsible board to assess an administrative fine of $100 on a healing arts licensee for each violation. The bill would require the board to assess an administrative fine of $100 on a health care employer for each physician and surgeon who the employer employs and who would have been fined for violating the bills provisions. The bill would require that the administrative fines be deposited in the state General Fund and would declare that they be used, upon appropriation by the Legislature, to enforce the provisions of the bill.This bill would define other terms for its purposes. A violation of the bills provisions would constitute unprofessional conduct. The bill would specify that these provisions do not apply to a physician and surgeon or an osteopathic physician and surgeon working in a hospital emergency room.
Existing law, the Medical Practice Act, establishes the Medical Board of California within the Department of Consumer Affairs and sets forth its powers and duties relating to the licensure and regulation of physicians and surgeons. Existing law establishes the Osteopathic Medical Board of California within the department and sets forth its powers and duties relating to the licensure and regulation of osteopathic physicians and surgeons.
Under existing law, it is unlawful for healing arts licensees, except as specified, to offer, deliver, receive, or accept any rebate, refund, commission, preference, patronage dividend, discount, or other consideration, in the form of money or otherwise, as compensation or inducement for referring patients, clients, or customers to any person, subject to certain exceptions. Existing law also prohibits specified healing arts licensees from charging, billing, or otherwise soliciting payment from a patient on behalf of, or referring a patient to, an organization in which the licensee, or the licensees immediate family, has a significant beneficial interest, unless the licensee first makes specified disclosures in writing to the patient.
Existing federal law known as the Open Payments program requires, among other things, applicable manufacturers of drugs, devices, and biological or medical supplies to annually report to the federal Secretary of Health and Human Services certain payments and other transfers of value made to covered recipients, as defined.
This bill would require a physician and surgeon, defined to include a physician and surgeon licensed pursuant to the Medical Practice Act or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act, who receives remuneration from a drug or device company, to disclose the source of the remuneration orally and in writing to each patient prior to the intended use or prescription of a device or drug manufactured or distributed by the company, as prescribed. The bill would also define other terms for its purposes. Under the bill, a violation of this disclosure provision would constitute unprofessional conduct.
This bill would require a physician and surgeon to post an open payments database notice, as described, in each location where the licensee practices and in an area that is likely to be seen by all persons who enter the office. The bill would require a physician and surgeon to conspicuously post the same open payments database notice on the internet website used for the physician and surgeons practice. The bill would require a health care employer to comply with these posting requirements instead if the physician and surgeon is employed by the health care employer.
This bill would require the responsible board to assess an administrative fine of $100 on a healing arts licensee for each violation. The bill would require the board to assess an administrative fine of $100 on a health care employer for each physician and surgeon who the employer employs and who would have been fined for violating the bills provisions. The bill would require that the administrative fines be deposited in the state General Fund and would declare that they be used, upon appropriation by the Legislature, to enforce the provisions of the bill.
This bill would specify that these provisions do not apply to a physician and surgeon or an osteopathic physician and surgeon working in a hospital emergency room.
For purposes of this article, all of the following definitions apply:
(a)Drug or device company means a manufacturer, developer, or distributor of pharmaceutical drugs or any device used in the context of the physician and surgeons or osteopathic physician and surgeons practice.
(b)Health care employer means an employer that provides health care services and that employs a physician and surgeon or an osteopathic physician and surgeon.
(c)Open Payments database means the database created to allow the public to search for data provided pursuant to Section 1320a-7h of Title 42 of the United States Code and that is maintained by the federal Centers for Medicare and Medicaid Services.
(d)Physician and surgeon includes a physician and surgeon licensed pursuant to the Medical Practice Act (Chapter 5 (commencing with Section 2000)) or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act.
661.(a)A physician and surgeon shall provide to each patient at the initial office visit a written or electronic notice of the Open Payments database. The written notice shall include a signature from the patient or a patient representative and the date of signature.
(b)The written or electronic notice shall contain the following text:
The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov.
(c)A physician and surgeon shall include in the electronic records for the patient a record of the notice pursuant to this section.
(d)If a physician and surgeon does not maintain electronic records, the physician and surgeon shall include the notice pursuant to this section in the written records.
(e)A physician and surgeon shall give to the patient or patient representative a copy of the signed and dated notice.
663.(a)(1)Notwithstanding any law, except as provided in subdivision (c), a physician and surgeon shall post in each location where the physician and surgeon practices, in an area that is likely to be seen by all persons who enter the office, an Open Payments database notice.
(2)The Open Payments database notice described in paragraph (1) shall include both of the following:
(A)An internet website link to the Open Payments database.
(B)The following text:
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
(b)Beginning January 1, 2024, if an internet website is used for a physician and surgeons practice, then the physician and surgeon shall conspicuously post the Open Payments database notice described in subdivision (a) on that internet website, except as otherwise authorized under subdivision (c).
(c)Notwithstanding subdivisions (a) and (b), if a physician and surgeon subject to this section is employed by a health care employer, the health care employer shall be responsible for meeting the requirements of this section.
(d)A posting required by this section may be placed within the same notice posted by the physician and surgeon in accordance with Section 138 or 2026.
664.A violation of this article shall constitute unprofessional conduct.
665.This article does not apply to a physician and surgeon working in a hospital emergency room.
For purposes of this article, all of the following definitions apply:
(a)Drug or device company means a manufacturer, developer, or distributor of pharmaceutical drugs or any device used in the context of the physician and surgeons or osteopathic physician and surgeons practice.
(b)Health care employer means an employer that provides health care services and that employs a physician and surgeon or an osteopathic physician and surgeon.
(c)Open Payments database means the database created to allow the public to search for data provided pursuant to Section 1320a-7h of Title 42 of the United States Code and that is maintained by the federal Centers for Medicare and Medicaid Services.
(d)Physician and surgeon includes a physician and surgeon licensed pursuant to the Medical Practice Act (Chapter 5 (commencing with Section 2000)) or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act.
661.(a)A physician and surgeon shall provide to each patient at the initial office visit a written or electronic notice of the Open Payments database. The written notice shall include a signature from the patient or a patient representative and the date of signature.
(b)The written or electronic notice shall contain the following text:
The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov.
(c)A physician and surgeon shall include in the electronic records for the patient a record of the notice pursuant to this section.
(d)If a physician and surgeon does not maintain electronic records, the physician and surgeon shall include the notice pursuant to this section in the written records.
(e)A physician and surgeon shall give to the patient or patient representative a copy of the signed and dated notice.
663.(a)(1)Notwithstanding any law, except as provided in subdivision (c), a physician and surgeon shall post in each location where the physician and surgeon practices, in an area that is likely to be seen by all persons who enter the office, an Open Payments database notice.
(2)The Open Payments database notice described in paragraph (1) shall include both of the following:
(A)An internet website link to the Open Payments database.
(B)The following text:
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
(b)Beginning January 1, 2024, if an internet website is used for a physician and surgeons practice, then the physician and surgeon shall conspicuously post the Open Payments database notice described in subdivision (a) on that internet website, except as otherwise authorized under subdivision (c).
(c)Notwithstanding subdivisions (a) and (b), if a physician and surgeon subject to this section is employed by a health care employer, the health care employer shall be responsible for meeting the requirements of this section.
(d)A posting required by this section may be placed within the same notice posted by the physician and surgeon in accordance with Section 138 or 2026.
664.A violation of this article shall constitute unprofessional conduct.
665.This article does not apply to a physician and surgeon working in a hospital emergency room.
For purposes of this article, all of the following definitions apply:
(a)Drug or device company means a manufacturer, developer, or distributor of pharmaceutical drugs or any device used in the context of the physician and surgeons or osteopathic physician and surgeons practice.
(b)Health care employer means an employer that provides health care services and that employs a physician and surgeon or an osteopathic physician and surgeon.
(c)Open Payments database means the database created to allow the public to search for data provided pursuant to Section 1320a-7h of Title 42 of the United States Code and that is maintained by the federal Centers for Medicare and Medicaid Services.
(d)Physician and surgeon includes a physician and surgeon licensed pursuant to the Medical Practice Act (Chapter 5 (commencing with Section 2000)) or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act.
661.(a)A physician and surgeon shall provide to each patient at the initial office visit, and every two years thereafter, visit a written or electronic notice of the Open Payments database. The written notice shall include a signature from the patient or a patient representative and the date of signature. If a patient does not seek treatment within a 12-month period, the notice shall be made at the next office or telehealth visit.
(b)The written or electronic notice shall contain the following text:
The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov.
(c)A physician and surgeon shall include in the electronic records for the patient a record of the notice pursuant to this section.
(d)If a physician and surgeon does not maintain electronic records, the physician and surgeon shall include the notice pursuant to this section in the written records. The notice may include more than one signature line to enable the same record to be used for multiple years.
(e)A physician and surgeon shall give to the patient or patient representative a copy of the signed and dated notice.
663.(a)(1)Notwithstanding any law, except as provided in subdivision (c), a physician and surgeon shall post in each location where the physician and surgeon practices, in an area that is likely to be seen by all persons who enter the office, an Open Payments database notice.
(2)The Open Payments database notice described in paragraph (1) shall include both of the following:
(A)An internet website link to the Open Payments database.
(B)The following text:
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
(b)Except as provided in subdivision (c), a physician and surgeon shall conspicuously post the Open Payments database notice described in subdivision (a) on the internet website used for the physician and surgeons practice.(b)Beginning January 1, 2024, if an internet website is used for a physician and surgeons practice, then the physician and surgeon shall conspicuously post the Open Payments database notice described in subdivision (a) on that internet website, except as otherwise authorized under subdivision (c).
(c)Notwithstanding subdivisions (a) and (b), if a physician and surgeon subject to this section is employed by a health care employer, the health care employer shall be responsible for meeting the requirements of this section.
(d)A posting required by this section may be placed within the same notice posted by the physician and surgeon in accordance with Section 138 or 2026.
664.A violation of this article shall constitute unprofessional conduct.
665.This article does not apply to a physician and surgeon working in a hospital emergency room.
For purposes of this article, all of the following definitions apply:
(a)Drug or device company means a manufacturer, developer, or distributor of pharmaceutical drugs or any device used in the context of the physician and surgeons or osteopathic physician and surgeons practice.
(b)Health care employer means an employer that provides health care services and that employs a physician and surgeon or an osteopathic physician and surgeon.
(c)Open Payments database means the database created to allow the public to search for data provided pursuant to Section 1320a-7h of Title 42 of the United States Code and that is maintained by the federal Centers for Medicare and Medicaid Services.
(d)Physician and surgeon includes a physician and surgeon licensed pursuant to the Medical Practice Act (Chapter 5 (commencing with Section 2000)) or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act.
661.(a)A physician and surgeon shall provide to each patient at the initial office visit, and at an office or telehealth visit annually every two years thereafter, a written notice of the Open Payments database. The written notice shall include a signature from the patient or a patient representative and the date of signature. If a patient does not seek treatment within a 12-month period, the notice shall be made at the next office or telehealth visit.
(b)The written notice shall contain the following text:
The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov.
(c)A physician and surgeon shall include in the written or electronic records for the patient a record of the notice pursuant to this section.
(d)If a physician and surgeon does not maintain electronic records, the physician and surgeon shall include the notice pursuant to this section in the written records. The notice may include more than one signature line to enable the same record to be used for multiple years.
(d)(e)A physician and surgeon shall give to the patient or patient representative a copy of the signed and dated notice.
663.(a)(1)Notwithstanding any law, except as provided in subdivision (c), a physician and surgeon shall post in each location where the physician and surgeon practices, in an area that is likely to be seen by all persons who enter the office, an Open Payments database notice.
(2)The Open Payments database notice described in paragraph (1) shall include both of the following:
(A)An internet website link to the Open Payments database.
(B)The following text:
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
(b)Except as provided in subdivision (c), a physician and surgeon shall conspicuously post the Open Payments database notice described in subdivision (a) on the internet website used for the physician and surgeons practice.
(c)Notwithstanding subdivisions (a) and (b), if a physician and surgeon subject to this section is employed by a health care employer, the health care employer shall be responsible for meeting the requirements of this section.
(d)A posting required by this section may be placed within the same notice posted by the physician and surgeon in accordance with Section 138 or 2026.
664.A violation of this article shall constitute unprofessional conduct.
665.This article does not apply to a physician and surgeon working in a hospital emergency room.
For purposes of this article, all of the following definitions apply:
(a)Drug or device company means a manufacturer, developer, or distributor of pharmaceutical drugs or any device used in the context of the physician and surgeons or osteopathic physician and surgeons practice.
(b)Health care employer means an employer that provides health care services and that employs a physician and surgeon or an osteopathic physician and surgeon.
(c)Open Payments database means the database created to allow the public to search for data provided pursuant to Section 1320a-7h of Title 42 of the United States Code and that is maintained by the federal Centers for Medicare and Medicaid Services.
(d)Physician and surgeon includes a physician and surgeon licensed pursuant to the Medical Practice Act (Chapter 5 (commencing with Section 2000)) or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act.
661.(a)A physician and surgeon shall provide to each patient at the initial office visit, and at an office or telehealth visit annually thereafter, a written notice of the Open Payments database. The written notice shall include a signature from the patient or a patient representative and the date of signature. If a patient does not seek treatment within a 12-month period, the notice shall be made at the next office or telehealth visit.
(b)The written notice shall contain the following text:
The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov.
(c)A physician and surgeon shall include in the written or electronic records for the patient a record of the notice pursuant to this section.
(d)A physician and surgeon shall give to the patient or patient representative a copy of the signed and dated notice.
662.(a)A physician and surgeon shall provide to each patient at the initial office visit, and at an office or telehealth visit annually thereafter, a written disclosure of the names of all drug and device companies the physician and surgeon received payment or transfers of value from as reported on the Open Payments database for the three most recent years available. If a patient does not seek treatment within a 12-month period, the disclosure shall be made at the next office or telehealth visit.(b)A physician and surgeon shall include in the written or electronic records for the patient a record of the disclosure pursuant to this section.(c)A physician and surgeon shall give to the patient or patient representative a copy of the signed and dated disclosure.663.(a)(1)Notwithstanding any law, except as provided in subdivision (c), a physician and surgeon shall post in each location where the physician and surgeon practices, in an area that is likely to be seen by all persons who enter the office, an Open Payments database notice.
(2)The Open Payments database notice described in paragraph (1) shall include both of the following:
(A)An internet website link to the Open Payments database.
(B)The following text:
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
(b)Except as provided in subdivision (c), a physician and surgeon shall conspicuously post the Open Payments database notice described in subdivision (a) on the internet website used for the physician and surgeons practice.
(c)Notwithstanding subdivisions (a) and (b), if a physician and surgeon subject to this section is employed by a health care employer, the health care employer shall be responsible for meeting the requirements of this section.
(d)A posting required by this section may be placed within the same notice posted by the physician and surgeon in accordance with Section 138 or 2026.
664.A violation of this article shall constitute unprofessional conduct.
665.This article does not apply to a physician and surgeon working in a hospital emergency room.
For purposes of this article, all of the following definitions apply:
(a)Drug or device company means a manufacturer, developer, or distributor of pharmaceutical drugs or any device used in the context of the physician and surgeons or osteopathic physician and surgeons practice.
(b)Health care employer means an employer that provides health care services and that employs a physician and surgeon or an osteopathic physician and surgeon.
(c)Open payments Payments database means the database created to allow the public to search for data provided pursuant to Section 1320a-7h of Title 42 of the United States Code and that is maintained by the federal Centers for Medicare and Medicaid Services.
(d)Physician and surgeon includes a physician and surgeon licensed pursuant to the Medical Practice Act (Chapter 5 (commencing with Section 2000)) or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act.
661.(a)A physician and surgeon who receives a payment or transfer of value from a drug or device company shall disclose the source of the payment or transfer of value in writing to each patient or patient representative prior to the intended use or prescription of a device or drug manufactured or distributed by the company. The disclosure shall cover any payment or transfer of value received on or after January 1, 2014. The written disclosure shall include a signature from the patient or patient representative and the date of signature.(b)The written disclosure pursuant to subdivision (a) shall contain the following text:If you would like further details on the information provided above you may discuss with Dr. ____ and/or visit openpaymentsdata.cms.gov, a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals.(c)A physician and surgeon shall include in the written or electronic records for the patient a record of disclosure pursuant to this section.(d)A physician and surgeon shall give to the patient or patient representative a copy of the signed and dated disclosure.661.(a)A physician and surgeon shall provide to each patient at the initial office visit, and at an office or telehealth visit annually thereafter, a written notice of the Open Payments database. The written notice shall include a signature from the patient or a patient representative and the date of signature. If a patient does not seek treatment within a 12-month period, the notice shall be made at the next office or telehealth visit.
(b)The written notice shall contain the following text:
The Open Payments database is a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov.
(c)A physician and surgeon shall include in the written or electronic records for the patient a record of the notice pursuant to this section.
(d)A physician and surgeon shall give to the patient or patient representative a copy of the signed and dated notice.
662.(a)A physician and surgeon shall provide to each patient at the initial office visit, and at an office or telehealth visit annually thereafter, a written disclosure of the names of all drug and device companies the physician and surgeon received payment or transfers of value from as reported on the Open Payments database for the three most recent years available. If a patient does not seek treatment within a 12-month period, the disclosure shall be made at the next office or telehealth visit.
(b)A physician and surgeon shall include in the written or electronic records for the patient a record of the disclosure pursuant to this section.
(c)A physician and surgeon shall give to the patient or patient representative a copy of the signed and dated disclosure.
662.663.(a)(1)Notwithstanding any law, except as provided in subdivision (c), a physician and surgeon shall post in each location where the physician and surgeon practices, in an area that is likely to be seen by all persons who enter the office, an open payments Open Payments database notice.
(2)The open payments Open Payments database notice described in paragraph (1) shall include both of the following:
(A)An internet website link to the open payments Open Payments database.
(B)The following text:
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
(b)Except as provided in subdivision (c), a physician and surgeon shall conspicuously post the open payments Open Payments database notice described in subdivision (a) on the internet website used for the physician and surgeons practice.
(c)Notwithstanding subdivisions (a) and (b), if a physician and surgeon subject to this section is employed by a health care employer, the health care employer shall be responsible for meeting the requirements of this section.
(d)A posting required by this section may be placed within the same notice posted by the physician and surgeon in accordance with Section 138 or 2026.
663.664.A violation of this article shall constitute unprofessional conduct.
664.665.This article does not apply to a physician and surgeon working in a hospital emergency room.
For purposes of this article, all of the following definitions apply:
(a)Drug or device company means a manufacturer, developer, or distributor of pharmaceutical drugs or any device used in the context of the physician and surgeons or osteopathic physician and surgeons practice.
(b)Health care employer means an employer that provides health care services and that employs a physician and surgeon or an osteopathic physician and surgeon.
(c)Open payments database means the database created to allow the public to search for data provided pursuant to Section 1320a-7h of Title 42 of the United States Code and that is maintained by the federal Centers for Medicare and Medicaid Services.
(d)Physician and surgeon includes a physician and surgeon licensed pursuant to the Medical Practice Act (Chapter 5 (commencing with Section 2000)) or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act.
661.(a)A physician and surgeon who receives remuneration a payment or transfer of value from a drug or device company shall disclose the source of the remuneration orally and payment or transfer of value in writing to each patient or patient representative prior to the intended use or prescription of a device or drug manufactured or distributed by the company. The disclosure shall cover any remuneration payment or transfer of value received on or after January 1, 2014. The written disclosure shall include a signature from the patient or patient representative and the date of signature.
(b)The written disclosure pursuant to subdivision (a) shall contain the following text:
If you would like further details on the information provided above you may discuss with Dr. ____ and/or visit openpaymentsdata.cms.gov, a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals.
(c)A physician and surgeon shall include in the written or electronic records for the patient a record of disclosure pursuant to this section.
(d)A physician and surgeon shall give to the patient or patient representative a copy of the signed and dated disclosure.
662.(a)(1)Notwithstanding any law, except as provided in subdivision (c), a physician and surgeon shall post in each location where the physician and surgeon practices, in an area that is likely to be seen by all persons who enter the office, an open payments database notice.
(2)The open payments database notice described in paragraph (1) shall include both of the following:
(A)An internet website link to the open payments database.
(B)The following text:
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
(b)Except as provided in subdivision (c), a physician and surgeon shall conspicuously post the open payments database notice described in subdivision (a) on the internet website used for the physician and surgeons practice.
(c)Notwithstanding subdivisions (a) and (b), if a physician and surgeon subject to this section is employed by a health care employer, the health care employer shall be responsible for meeting the requirements of this section.
(d)A posting required by this section may be placed within the same notice posted by the physician and surgeon in accordance with Section 138 or 2026.
663.A violation of this article shall constitute unprofessional conduct.
664.This article does not apply to a physician and surgeon working in a hospital emergency room.
For purposes of this article, all of the following definitions apply:
(a)Drug or device company means a manufacturer, developer, or distributor of pharmaceutical drugs or any device used in the context of the physician and surgeons or osteopathic physician and surgeons practice.
(b)Health care employer means an employer that provides health care services and that employs a physician and surgeon or an osteopathic physician and surgeon.
(c)Open payments database means the database created to allow the public to search for data provided pursuant to Section 1320a-7h of Title 42 of the United States Code and that is maintained by the federal Centers for Medicare and Medicaid Services.
(d)Physician and surgeon includes a physician and surgeon licensed pursuant to the Medical Practice Act (Chapter 5 (commencing with Section 2000)) or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act.
661.(a)(1)A physician and surgeon who receives remuneration from a drug or device company shall disclose the source of the remuneration orally and in writing to each patient or patient representative prior to the intended use or prescription of a device or drug manufactured or distributed by the company. A The disclosure shall cover any remuneration received on or after January 1, 2014. The written disclosure shall include a signature from the patient is required on the written disclosure. or patient representative and the date of signature.
(2)(b)The written disclosure pursuant to paragraph (1) subdivision (a) shall contain the following text:
If you would like further details on the information provided above you may discuss with Dr. ____ and/or visit openpaymentsdata.cms.gov, a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals.
(b)A violation of this section shall constitute unprofessional conduct.(c)A physician and surgeon shall include in the written or electronic records for the patient a record of disclosure pursuant to this section.
(d)A physician and surgeon shall give to the patient or patient representative a copy of the signed and dated disclosure.
662.(a)(1)Notwithstanding any law, except as provided in subdivision (c), a physician and surgeon shall post in each location where the physician and surgeon practices, in an area that is likely to be seen by all persons who enter the office, an open payments database notice.
(2)The open payments database notice described in paragraph (1) shall include both of the following:
(A)An internet website link to the open payments database.
(B)A brief description of the purpose of the open payments database. The following text:
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
(b)Except as provided in subdivision (c), a physician and surgeon shall conspicuously post the open payments database notice described in subdivision (a) on the internet website used for the physician and surgeons practice.
(c)Notwithstanding subdivisions (a) and (b), if a physician and surgeon subject to this section is employed by a health care employer, the health care employer shall be responsible for meeting the requirements of this section.
663.(a)(1)The Medical Board of California or the Osteopathic Medical Board of California, as applicable, shall assess an administrative fine of one hundred dollars ($100) on a physician and surgeon for each violation of this article.(2)For violations by a health care employer pursuant to subdivision (c) of Section 662, the Medical Board of California or the Osteopathic Medical Board of California, as applicable, shall assess an administrative fine of one hundred dollars ($100) on the health care employer for each violation by each physician and surgeon who is employed by the health care employer and who would have been fined for violating subdivision (a) or (b) of Section 662.(b)Administrative fines collected pursuant to this section shall be deposited in the state General Fund and shall be used, upon appropriation by the Legislature, to enforce this article.663.A violation of this article shall constitute unprofessional conduct.
664.This article does not apply to a physician and surgeon or an osteopathic physician and surgeon working in a hospital emergency room.
For purposes of this article, all of the following definitions apply:
(a)Drug or device company means a manufacturer, developer, or distributor of pharmaceutical drugs or any device used in the context of the physician and surgeons or osteopathic physician and surgeons practice.
(b)Health care employer means an employer that provides health care services and that employs a physician and surgeon or an osteopathic physician and surgeon.
(c)Open payments database means the database created to allow the public to search for data provided pursuant to Section 1320a-7h of Title 42 of the United States Code and that is maintained by the federal Centers for Medicare and Medicaid Services.
(d)Physician and surgeon includes a physician and surgeon licensed pursuant to the Medical Practice Act (Chapter 5 (commencing with Section 2000)) or an osteopathic physician and surgeon licensed by the Osteopathic Medical Board of California under the Osteopathic Act.
661.(a)(1)A physician and surgeon who receives remuneration from a drug or device company shall disclose the source of the remuneration orally and in writing to each patient prior to the intended use or prescription of a device or drug manufactured or distributed by the company. A signature from the patient is required on the written disclosure.
(2)The written disclosure pursuant to paragraph (1) shall contain the following text:
If you would like further details on the information provided above you may discuss with Dr. ____ and/or visit openpaymentsdata.cms.gov, a federal tool used to search payments made by drug and device companies to physicians and teaching hospitals.
(b)A violation of this section shall constitute unprofessional conduct.
662.(a)(1)Notwithstanding any law, except as provided in subdivision (c), a physician and surgeon shall post in each location where the physician and surgeon practices, in an area that is likely to be seen by all persons who enter the office, an open payments database notice.
(2)The open payments database notice described in paragraph (1) shall include both of the following:
(A)An internet website link to the open payments database.
(B)A brief description of the purpose of the open payments database.
(b)Except as provided in subdivision (c), a physician and surgeon shall conspicuously post the open payments database notice described in subdivision (a) on the internet website used for the physician and surgeons practice.
(c)Notwithstanding subdivisions (a) and (b), if a physician and surgeon subject to this section is employed by a health care employer, the health care employer shall be responsible for meeting the requirements of this section.
663.(a)(1)The Medical Board of California or the Osteopathic Medical Board of California, as applicable, shall assess an administrative fine of one hundred dollars ($100) on a physician and surgeon for each violation of this article.
(2)For violations by a health care employer pursuant to subdivision (c) of Section 662, the Medical Board of California or the Osteopathic Medical Board of California, as applicable, shall assess an administrative fine of one hundred dollars ($100) on the health care employer for each violation by each physician and surgeon who is employed by the health care employer and who would have been fined for violating subdivision (a) or (b) of Section 662.
(b)Administrative fines collected pursuant to this section shall be deposited in the state General Fund and shall be used, upon appropriation by the Legislature, to enforce this article.
664.This article does not apply to a physician and surgeon or an osteopathic physician and surgeon working in a hospital emergency room.
|
Date
|
Status
|
|---|---|
| Sep 29, 2022 | Chaptered by Secretary of State - Chapter 750, Statutes of 2022. |
| Sep 29, 2022 | Approved by the Governor. |
| Sep 7, 2022 | Enrolled and presented to the Governor at 4 p.m. |
| Aug 30, 2022 | In Assembly. Concurrence in Senate amendments pending. |
| Aug 30, 2022 | Read third time. Passed. Ordered to the Assembly. (Ayes 21. Noes 4. Page 5242.). |
| Aug 25, 2022 | Read third time and amended. Ordered to third reading. |
| Aug 15, 2022 | Read second time. Ordered to third reading. |
| Aug 11, 2022 | From committee: Amend, and do pass as amended. (Ayes 5. Noes 1.) (August 11). |
| Aug 26, 2021 | In committee: Held under submission. |
| Aug 23, 2021 | In committee: Referred to APPR suspense file. |
| Aug 16, 2021 | In committee: Hearing postponed by committee. |
| Jul 13, 2021 | Read second time and amended. Re-referred to Com. on APPR. |
| Jul 12, 2021 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (July 12). |
| Jun 8, 2021 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B., P. & E.D. |
| May 12, 2021 | Referred to Com. on B., P. & E.D. |
| May 4, 2021 | In Senate. Read first time. To Com. on RLS. for assignment. |
| May 3, 2021 | Read third time. Passed. Ordered to the Senate. (Ayes 54. Noes 9. Page 1281.) |
| Apr 29, 2021 | Read second time. Ordered to third reading. |
| Apr 28, 2021 | From committee: Do pass. (Ayes 12. Noes 0.) (April 28). |
| Apr 19, 2021 | Re-referred to Com. on APPR. |
| Apr 15, 2021 | Read second time and amended. |
| Apr 14, 2021 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 13. Noes 0.) (April 13). |
| Mar 18, 2021 | Re-referred to Com. on B. & P. |
| Mar 17, 2021 | From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended. |
| Mar 4, 2021 | Referred to Com. on B. & P. |
| Feb 22, 2021 | Read first time. |
| Feb 20, 2021 | From printer. May be heard in committee March 22. |
| Feb 19, 2021 | Introduced. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 30, 2022 | Assembly 3rd Reading AB1278 Nazarian By Allen | Senate Floor |
Passed |
|
| Aug 30, 2022 | AB 1278 Nazarian Concurrence in Senate Amendments | Assembly Floor |
Passed |
|
| May 3, 2021 | AB 1278 Nazarian Assembly Third Reading | Assembly Floor |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Bill Author
Bill Co-Author(s):